Abstract:Background: Mesenchymal stromal cells (MSCs) have broad potential as a cell therapy including for the treatment of drug-resistant inflammatory conditions with abnormal T cell proliferation such as graft-versus-host disease (GVHD). Clinical success, however, has been complicated by the heterogeneity of culture-expanded MSCs as well as donor variability. Here, we devise culture conditions that promote expansion of MSCs with enhanced immunomodulatory functions both in vitro and in animal models of GVHD. Methods: Human bone marrow-derived MSCs were expanded at high-confluency (MSCHC) and low-confluency state (MSCLC). Their immunomodulatory properties were evaluated with in vitro co-culture assays based on suppression of activated T cell proliferation and secretion of pro-inflammatory cytokines from activated T cells. Metabolic state of these cells was determined, while RNA sequencing was performed to explore transcriptome of these MSCs. Ex vivo expanded MSCHC or MSCLC was injected into human peripheral blood mononuclear cells (PBMC)-induced GVHD mouse model to determine their in vivo therapeutic efficacy based on clinical grade scoring, human CD45+ blood count and histopathological examination. Results: As compared to MSCLC, MSCHC significantly reduced both the proliferation of anti-CD3/CD28-activated T cells and secretion of pro-inflammatory cytokines upon MSCHC co-culture across several donors even in the absence of cytokine priming. Mechanistically, metabolic analysis of MSCHC prior to co-culture with activated T cells showed increased glycolytic metabolism and lactate secretion compared to MSCLC, consistent with their ability to inhibit T cell proliferation. Transcriptome analysis further revealed differential expression of immunomodulatory genes including TRIM29, BPIFB4, MMP3 and SPP1 in MSCHC as well as enriched pathways including cytokine-cytokine receptor interactions, cell adhesion and PI3K-AKT signalling. Lastly, we demonstrate in a human PBMC-induced GVHD mouse model that delivery of MSCHC showed greater suppression of inflammation and improved outcomes compared to MSCLC and saline controls. Conclusion: Our study provides evidence that ex vivo expansion of MSCs at high confluency alters the metabolic and transcriptomic states of these cells. Importantly, this approach maximizes the production of MSCs with enhanced immunomodulatory functions without priming, thus providing a non-invasive and generalizable strategy for improving the use of MSCs for the treatment of inflammatory diseases.

CD317+ MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities

Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties

Mesenchymal Stem Cells Prevent Overwhelming Inflammation and Reduce Infection Severity Via Recruiting CXCR3+ Regulatory T Cells

Improving the immunomodulatory function of mesenchymal stem cells by defined chemical approach

Comparable Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Collagen-Induced Arthritis to TNF Inhibitor or Anti-Cd20 Treatment.

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

Improved therapeutic consistency and efficacy of CD317+ MSCs through stabilizing TSG6 by PTX3

3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects

Cd106 Identifies A Subpopulation Of Mesenchymal Stem Cells With Unique Immunomodulatory Properties

Characterization of a CD23+CD43+Regulatory B Cell Subset in Human That Induced by Mesenchymal Stem Cells

MSC: Immunoregulatory Effects, Roles on Neutrophils and Evolving Clinical Potentials.

Mesenchymal Stem Cells: a Double-Edged Sword in Regulating Immune Responses

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells.

Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications

Serum-Free Medium Enhances the Therapeutic Effects of Umbilical Cord Mesenchymal Stromal Cells on a Murine Model for Acute Colitis

Dual-Functionalized MSCs That Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease.

Human Mesenchymal Stem Cell-Treated Regulatory CD23(+) CD43(+) B Cells Alleviate Intestinal Inflammation

Mesenchymal stem cells alleviate inflammatory responses through regulation of T-cell subsets

Eradication of Specific Donor-Dependent Variations of Mesenchymal Stem Cells in Immunomodulation to Enhance Therapeutic Values

Deconstructing transcriptional variations and their effects on immunomodulatory function among human mesenchymal stromal cells